rss-es – Página 72 – PRAIS 2.0

FDA Roundup: June 3, 2022

Murilo Freitas - 21:08, 2 de junio de 2022266

FDA Roundup: June 3, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-june-3-2022

FDA Infant Formula Update: June 3, 2022

Murilo Freitas - 15:53, 2 de junio de 2022280

FDA Infant Formula Update: June 3, 2022
http://www.fda.gov/news-events/press-announcements/fda-infant-formula-update-june-3-2022

Philips Respironics Recalls All V60 and V60 Plus Ventilators for Power Issue that May Cause Ventilator to Stop with or without Alarms

Murilo Freitas - 04:00, 2 de junio de 2022277

All Philips Respironics V60 and V60 Plus Ventilators are recalled due to a power issue that may cause ventilator to stop with or without an alarm.

http://www.fda.gov/medical-devices/medical-device-recalls/philips-respironics-recalls-all-v60-and-v60-plus-ventilators-power-issue-may-cause-ventilator-stop

FDA Launches New Dietary Supplement Education Initiative for Consumers, Educators, and Healthcare Professionals

Murilo Freitas - 15:05, 1 de junio de 2022274

FDA Launches New Dietary Supplement Education Initiative for Consumers, Educators, and Healthcare Professionals
http://www.fda.gov/news-events/press-announcements/fda-launches-new-dietary-supplement-education-initiative-consumers-educators-and-healthcare

FDA Infant Formula Update: June 2, 2022

Murilo Freitas - 14:09, 1 de junio de 2022439

FDA Infant Formula Update: June 2, 2022
http://www.fda.gov/news-events/press-announcements/fda-infant-formula-update-june-2-2022

rss rss-es rss-pt

UPDATE: FDA Updates Recommendations for the Use of Renuvion/J-Plasma Device for Certain Aesthetic Procedures: FDA Safety Communication

Murilo Freitas - 04:00, 1 de junio de 2022432

Renuvion/J-Plasma device with new handpiece can be used for certain aesthetic skin procedures.

http://www.fda.gov/medical-devices/safety-communications/update-fda-updates-recommendations-use-renuvionj-plasma-device-certain-aesthetic-procedures-fda

Ukoniq (umbralisib): Drug Safety Communication – FDA Approval of Lymphoma Medicine is Withdrawn Due to Safety Concerns

Murilo Freitas - 22:49, 31 de mayo de 2022307

Due to safety concerns, the FDA has withdrawn its approval for the cancer medicine Ukoniq (umbralisib). Updated findings from the UNITY-CLL clinical trial continued to show a possible increased risk of death in patients receiving Ukoniq.

http://www.fda.gov/safety/medical-product-safety-information/ukoniq-umbralisib-drug-safety-communication-fda-approval-lymphoma-medicine-withdrawn-due-safety

FDA Roundup: May 31, 2022

Murilo Freitas - 18:33, 30 de mayo de 2022307

FDA Roundup: May 31, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-may-31-2022

Walmart Inc. Issues Voluntary Nationwide Recall of Various Artri Ajo King Joint Supplements Due to Potential Hidden Drug Ingredients

Murilo Freitas - 04:00, 27 de mayo de 2022484

Walmart Inc. is voluntarily recalling all lots of Artri Ajo King Joint Supplements sold by Innovacion Naturals and PDX Supply Warehouse LLC on Walmart.com and shipped by Walmart to the consumer level. FDA laboratory analysis confirmed that Artri Ajo King Omega 3 Joint Support Supplement with LOTE LT

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/walmart-inc-issues-voluntary-nationwide-recall-various-artri-ajo-king-joint-supplements-due

FDA Roundup: May 27, 2022

Murilo Freitas - 18:17, 26 de mayo de 2022302

FDA Roundup: May 27, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-may-27-2022